BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28731491)

  • 1. Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.
    Marcy PY; Schiappa R; Ferrero JM; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Gal J; Ettaiche M; Chateau Y; Chamorey E
    J Vasc Access; 2017 Sep; 18(5):390-395. PubMed ID: 28731491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices].
    Marcy PY; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Michel C; Chateau Y; Ettaiche M; Ferrero JM; Chamorey E
    Bull Cancer; 2015 Apr; 102(4):301-15. PubMed ID: 25799876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
    Burbridge B; Goyal K
    J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
    Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
    World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life of cancer patients with peripherally inserted central catheter: a pilot study.
    Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W
    J Vasc Access; 2017 Sep; 18(5):396-401. PubMed ID: 28777395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
    Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
    Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of a specialized consultation prior to insertion of totally implantable access venous devices: Impact on cancellation rate and patient satisfaction.
    Colucci N; Gregoris A; Meyer J; Naiken SP; Staszewicz W; Gialamas E; Toso C; Abbassi Z
    Vascular; 2020 Dec; 28(6):816-820. PubMed ID: 32508290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.
    Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W
    J Vasc Access; 2017 Mar; 18(2):153-157. PubMed ID: 28218366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnosis as adjunct therapy to conscious sedation for venous access device implantation in breast cancer: A pilot study.
    Sterkers N; Chabrol JL; De Troyer J; Bonijol D; Darmon JC; Donnez O
    J Vasc Access; 2018 Jul; 19(4):382-386. PubMed ID: 29566587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retained embolized fragment of totally implantable central venous catheter in right ventricle: it is really necessary to remove?
    Tazzioli G; Gargaglia E; Vecchioni I; Papi S; Di Blasio P; Rossi R
    J Vasc Access; 2015; 16(5):431-3. PubMed ID: 26109543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion.
    Thomopoulos T; Meyer J; Staszewicz W; Bagetakos I; Scheffler M; Lomessy A; Toso C; Becker CD; Morel P
    Ann Vasc Surg; 2014 Feb; 28(2):345-50. PubMed ID: 24360633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation on external jugular vein cut-down approach for TIVAD implantation.
    Cavallaro G; Iorio O; Iossa A; De Angelis F; Avallone M; Massaro M; Mattia C; Silecchia G
    World J Surg Oncol; 2015 Aug; 13():243. PubMed ID: 26264364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.
    Song MG; Seo TS; Kang EY; Yong HS; Seo JH; Choi YY
    J Vasc Access; 2015; 16(4):315-20. PubMed ID: 25953212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.